Upregulation of Inflammatory Cytokines in Pulmonary Embolism Using Biochip-Array Profiling
The complex pathophysiology of pulmonary embolism (PE) involves hemostatic activation, inflammatory processes, cellular dysfunction, and hemodynamic derangements. Due to the heterogeneity of this disease, risk stratification and diagnosis remains challenging. Biochip-array technology provides an int...
Main Authors: | Emily Bontekoe BS, Yevgeniy Brailovsky DO, Debra Hoppensteadt PhD, Jack Bontekoe MD, Fakiha Siddiqui BDS, Joshua Newman MD, Omer Iqbal MD, FACC, Trent Reed DO, FACEP, Jawed Fareed PhD, FAHA, Amir Darki MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296211013107 |
Similar Items
-
Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
by: Fakiha Siddiqui BDS, et al.
Published: (2020-10-01) -
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
by: Trung Phan MD, et al.
Published: (2020-01-01) -
Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-12-01) -
Biomarkers of Thrombo-Inflammatory Responses in Pulmonary Embolism Patients With Pre-Existing Versus New-Onset Atrial Fibrillation
by: Dimpi Patel BA, et al.
Published: (2021-05-01) -
Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-01-01)